Conventional gene therapy of DMD is hindered by the large size of dystrophin cDNA (13,957 bp), which exceeds the optimal packaging capacity of commonly used viral vectors2, 3, 4. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.